Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models

A Novel Interleukin-10 Dna Mucosal Delivery System Attenuates Intestinal Inflammation in a Mouse Model

(2017) S. Del Carmen et al.   European Journal of Inflammation

Milk Fermented with a 15-Lipoxygenase-1-Producing Lactococcus Lactis Alleviates Symptoms of colitis in a Murine Model

(2015) Tessalia Saraiva et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis

(2014) Meritxell Zurita-Turk et al.   BMC BIOTECHNOLOGY

Correlation between fibronectin binding protein A expression level at the surface of recombinant lactococcus lactis and plasmid transfer in vitro and in vivo

(2014) Juliana F Almeida et al.   BMC MICROBIOLOGY

Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease

(2014) P.J. Basso et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Protective Effects of Lactococci Strains Delivering Either IL-10 Protein or cDNA in a TNBS-induced Chronic Colitis Model

(2014) Silvina del Carmen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

(2014) Colin Hill et al.   Nature Reviews Gastroenterology & Hepatology

Lactobacillus paracasei CBA L74 Metabolic Products and Fermented Milk for Infant Formula Have Anti-Inflammatory Activity on Dendritic Cells In Vitro and Protective Effects against Colitis and an Enteric Pathogen In Vivo

(2014) Elena Zagato et al.   PLoS One

Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis

(2014) Tessalia Luerce et al.   Gut Pathogens

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation

(2014) Rebeca Martín et al.   Human Vaccines & Immunotherapeutics

Anti-Inflammatory Properties of Streptococcus salivarius, a Commensal Bacterium of the Oral Cavity and Digestive Tract

(2013) Ghalia Kaci et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Genetically Engineered Immunomodulatory Streptococcus thermophilus Strains Producing Antioxidant Enzymes Exhibit Enhanced Anti-Inflammatory Activities

(2013) Silvina del Carmen et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update

(2013) Jean Guy LeBlanc et al.   FEMS MICROBIOLOGY LETTERS

Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice

(2013) Miranda L. Hanson et al.   GASTROENTEROLOGY

Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces

(2013) Bouasria Benbouziane et al.   JOURNAL OF BIOTECHNOLOGY

Why interleukin-10 supplementation does not work in Crohn’s disease patients

(2013) Gareth J Marlow   WORLD JOURNAL OF GASTROENTEROLOGY

Evaluation of the Anti-Inflammatory Effect of Milk Fermented by a Strain of IL-10-Producing Lactococcus lactis Using a Murine Model of Crohn’s Disease

(2012) Silvina del Carmen et al.   JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY

Anti-Inflammatory Lactobacillus rhamnosus CNCM I-3690 Strain Protects against Oxidative Stress and Increases Lifespan in Caenorhabditis elegans

(2012) Gianfranco Grompone et al.   PLoS One

Modifying the Protease, Antiprotease Pattern by Elafin Overexpression Protects Mice From Colitis

(2011) Jean–Paul Motta et al.   GASTROENTEROLOGY

Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide

(2011) E. M. Fernandez et al.   GUT

Yoghurt Consumption Regulates the Immune Cells Implicated in Acute Intestinal Inflammation and Prevents the Recurrence of the Inflammatory Process in a Mouse Model

(2011) SILVINA CHAVES et al.   JOURNAL OF FOOD PROTECTION

Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model

(2011) Raj Kumar Duary et al.   MOLECULAR BIOLOGY REPORTS

Antioxidant Properties of Probiotics and Their Protective Effects in the Pathogenesis of Radiation-Induced Enteritis and Colitis

(2010) Basileios G. Spyropoulos et al.   DIGESTIVE DISEASES AND SCIENCES

Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice

(2010) Laurie Watterlot et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice

(2010) Jean Guy LeBlanc et al.   JOURNAL OF BIOTECHNOLOGY

AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis

(2010) Silvia Caluwaerts et al.   ORAL ONCOLOGY

Lactococcus lactis Expressing either Staphylococcus aureus Fibronectin-Binding Protein A or Listeria monocytogenes Internalin A Can Efficiently Internalize and Deliver DNA in Human Epithelial Cells

(2009) S. Innocentin et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Regulation of immune responses by interleukin-27

(2009) Hiroki Yoshida et al.   IMMUNOLOGICAL REVIEWS

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

(2009) K Vandenbroucke et al.   Mucosal Immunology

Mechanisms of action of probiotics: Recent advances

(2008) S. C. Ng et al.   INFLAMMATORY BOWEL DISEASES

Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice

(2007) A. de Moreno de LeBlanc et al.   JOURNAL OF MEDICAL MICROBIOLOGY